A research team, led by Dr Michel Bouvier at the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal in Quebec, has used the Roche xCELLigence SP Instrument to measure changes in cell response following ligand. [ + ]

Lorne Infection & Immunity: Resistance to antibiotics is an increasingly serious threat to human health worldwide. Now, a new Wellcome Trust-funded partnership with scientists in Queensland is fighting back. [ + ]

The biotech industry’s heavy hitters in business development are about to gather in Queensland for the annual dedicated forum for business development professionals. [ + ]

A trial of Phosphagenics' (ASX:POH) new TPM/oxycodone patch design proves that the redesign improves drug delivery by 4.5 times the original prototype version. [ + ]

The understanding of diseases such as Parkinson’s and Alzheimer’s is set to take a step forward following groundbreaking technology which will enable cell analysis using automated 3D microscopy. The technology will allow for the automated identification, separation and analysis of cells as complex as nerve cells in the brain. [ + ]

Former CEO of Avantogen, Dr William Ardrey, is to appear in Perth Magistrates Court this Friday on 19 counts of fraud. [ + ]

Australian scientists say they have made a genetic breakthrough which could help in the fight against cancer. The Melbourne-based team says it has pinpointed a link between non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, and the ability of tumours to spread in the body. [ + ]

Stem cell scientists from the University of Queensland Centre for Clinical Research (UQCCR) have discovered a method for producing mesenchymal stem/stromal cells (MSCs) from human iPSCs that substantially improves on current methods and speeds up conversion time. [ + ]

Sydney-based Prima BioMed (ASX:PRR) has filed a registration for a dual-listing on the NASDAQ exchange, a move first announced in 2010. [ + ]

Lorne Cancer: The discovery of a key weakness in metastatic melanoma is a Sputnik moment in the treatment of this deadly cancer. Although Professor Richard Kefford thinks we’re still a long way from landing on the moon. [ + ]

AusBiotech has relaunched the employment section on its high-traffic website, giving members the opportunity to list vacancies free and qualified industry professionals access to the latest list of industry jobs. [ + ]

A diagnosis technique developed by researchers at the Riken Omics Science Center (OSC) has succeeded in detecting influenza virus infection in only 40 minutes and with 100 times the sensitivity of conventional methods. [ + ]

The science and research partnership between Australia and China has been put under the microscope in a report released by Minister for Science and Research, Senator Chris Evans. The report, Science and Research Collaboration between Australia and China, provides a detailed analysis of the growing links between Australia and its most important trading partner. [ + ]

Lab technology company LBT Innovations (ASX:LBT) has negotiated a less-than-hoped-for minimum royalty deal with licensee bioMérieux worth US$600,000 per year. [ + ]

Melbourne biotech BioDiem (ASX:BDM) has awarded Changchun BCHT an exclusive license for the China private sector market covering its influenza vaccine technology. [ + ]